ORTINLABSS

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2016.

Ortin Laboratories Limited has informed the Exchange that the trading window in respect of the Company's Securities shall remain closed for all the Directors/Officers/Designed Employees of the Company from the trading hours on November 03, 2016 till close of the trading hours on November 14, 2016 as per the code of Internal Procedure and Conduct for Prevention of Insider Trading adopted by the Company for declaration of un audited financial results for the quarter and half year ended 30.09.2016.

Significant increase in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response.

Significant increase in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

Ortin Laboratories Limited has informed the Exchange regarding Consolidated Scrutinizers Report

Ortin Laboratories Limited has submitted to the Exchange a copy of the outcome and the proceedings of the Annual General Meeting of the Company held on September 30, 2016. along with Scrutinizer Report.

Ortin Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting of the Company held on August 29, 2016.

Ortin Laboratories Limited has informed the Exchange that the trading window in respect of the Company's securities shall remain closed for all the Directors/Officers/Designed Employees of the company from the trading hours on August 25, 2016 till close of the trading hours on August 31, 2016 as per the code of internal procedure and Conduct for prevention of Insider Trading adopted by the Company for consideration of proposal of demerger of the business of the Company.

Ortin Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from September 24, 2016 to September 30, 2016 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on September 30, 2016.

Ortin Laboratories Limited has informed the Exchange that the Board of Directors in their meeting held on August 12, 2016 has considered and approved : (1) Appointment of Secretarial Auditors for the year 2016-17.

Ortin Laboratories Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2016.

Ortin Laboratories Limited has informed the Exchange that Trading window closure from August 5, 2016 to August 16, 2016.

Ortin Laboratories Limited has submitted to the Exchange the standalone financial results along with the Auditors Report for the period ended March 31, 2016.

Ortin Laboratories Limited has submitted to the Exchange the standalone financial results along with the Auditors Report for the period ended 31-Mar-2016.

Ortin Laboratories Limited has informed the Exchange that the trading window in respect of the Company's Securities shall remain closed for all the Directors/Officers/Designed Employees of the Company from the trading hours on May 17, 2016 till close of the trading hours on June 01, 2016 as per the code of lnternal Procedure and Conduct for Prevention of lnsider Trading adopted by the Company fordeclaration of audited financial results for the quarter and year ended March 31, 2016. Trading window closure for consideration of audited financial results for the quarter and year ended March 31, 20

S. Murali Krishna Murthy has submitted to the Exchange vide letter dated April 04, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Ortin Laboratories Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended December 31, 2015.

Ortin Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on February 11, 2016.

Ortin Laboratories Limited has informed the Exchange that as per the Company's internal Code for Prevention of Insider Trading (as amended w.e.f 15.05.2015) the trading window for dealing in the securities of the Company is closed for the Company's Directors / Officers and designated employees of the Company from February 01, 2016 and will re-open 48 hours after the publication of the December quarter end results to the public in the Board Meeting scheduled to be held on February 11, 2016.

Ortin Laboratories Limited has informed the Exchange the names and contact details of Key Managerial Personnel (KMPs) authorised to determine materiality of an events or information and for the purpose of making disclosures to Stock Exchange.

Ortin Laboratories Limited has informed the Exchange that at the meeting of the Board of Directors of the Company held on November 14, 2015, the following were duly considered and approved :1. Change of registered office of the Company within the city limits.

Ortin Laboratories Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2015.

Ortin Laboratories Limited has informed the Exchange that the trading window for dealing in the securities of the Company is closed for the Company's Directors / Officers and designated employees of the Company from November 04, 2015 and will re-open 48 hours after the publication of the September quarter results to the public in the Board Meeting scheduled to be held on November 14, 2015.

Clarification by Ortin Laboratories LimitedSignificant price movement has been observed in Ortin Laboratories Limited.The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company.Ortin Laboratories Limitedhas vide its letter inter-alia stated, "With reference to the subject cited, we wish to clarify that there is no any specific information or announcement including pending announcement with the Company which in turn may have bearing on the price

Ortin Laboratories Limited has informed the Exchange regarding the outcome of the Annual General Meeting held on September 30, 2015 along with the scrutinizer report

Ortin Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from September 26, 2015 to September 30, 2015 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on September 30, 2015.